Výsledky vyhledávání - "Charles McNally"

Comparative study of dose delivery and cascade impaction performance of four metered-dose inhaler and spacer combinations

Autor: John J. Glennon, R.Harris Cummings, Alfred G. Childers, Janet Lim, Charles McNally, Brian D. Kaufman, Ernest L. Kelly

Publikováno v: Current Therapeutic Research. 57:75-87

This study compared the dose delivery and cascade impaction performance, including mass median aerodynamic diameter (MMAD) and respirable dose (RD), of four metered-dose inhaler (MDI) and spacer combinations (Aerobid ® and AeroChamber ® , Beclovent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::838ebfb28d41d5514d21421171040232
https://doi.org/10.1016/s0011-393x(96)80001-4

Zobrazit plný text záznamu

CLINICAL EFFICACY AND SAFETY OF LOWER-DOSE INDAPAMIDE THERAPY IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE HYPERTENSION

Autor: Charles McNally, Joseph Codispoti, Michael Shook, Robert J. Weiss, Stephen R. Zellner, E. Eugene Miller, Arthur Stokes, Phillip D. Toth

Publikováno v: American Journal of Therapeutics. 1:58-64

Previous clinical studies with indapamide, an indoline antihypertensive drug with diuretic and vasodilating activities, have shown a dose relationship associated with potassium loss. Two placebo-controlled, randomized, double-blind, parallel clinical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::380e847cf16c6c472a217cd0549ccc83
https://doi.org/10.1097/00045391-199406000-00010

Zobrazit plný text záznamu

Combination Treatment with Sustained-Release Verapamil and Indapamide in the Treatment of Mild-to-Moderate Hypertension

Autor: Michael A. Weber, Charles McNally, Arthur Stokes, David H.G. Smith, Matthew R. Weir, Stanley S. Franklin, Joseph Codispoti

Publikováno v: American journal of therapeutics. 3(7)

A multicenter study of the treatment of mild and moderate hypertension compared three once-daily regimens for efficacy and safety: Group I, verapamil sustained release (SR) 240 mg; Group II, verapamil SR 480 mg; and Group III, combination therapy of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ceb58ae5dba5aa7f75271d217e0a84
https://pubmed.ncbi.nlm.nih.gov/11862282

Zobrazit plný text záznamu

Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis

Autor: William R. Lumry, Arthur Stokes, David I. Bernstein, Andrew Pedinoff, Robert M. Cohen, Janet Lim, Peter S. Creticos, William C. Howland, Paul H. Ratner, D.F. Graft, Charles McNally, William W. Busse

Publikováno v: The Journal of allergy and clinical immunology. 97(3)

Background: Few clinical trials have directly compared the efficacy of antihistamines with topical nasal corticosteroids. Objective: The study was performed to compare the efficacy and safety of triamcinolone acetonide nasal spray at a dose of 110 μ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1765ac20e63c63e9a239e3caff7c1809
https://pubmed.ncbi.nlm.nih.gov/8613630

Zobrazit plný text záznamu

Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension

Autor: Arthur Stokes, Nader S. Jallad, Adesh K. Jain, Joseph Codispoti, Donald J. Weidler, Charles McNally, Harold W. Schnaper, Phillip D. Toth, Charles L. Curry, Keith C. Ferdinand

Publikováno v: Journal of clinical pharmacology. 35(1)

A low dose (1.25 mg) of indapamide (Lozol®, Rhone-Poulenc Rorer Pharmaceuticals, Collegeville, PA) was evaluated in 222 elderly patients (≥50 years) with mild to moderate essential hypertension in a multicenter, randomized, double-blind, parallel-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc59db3e12753e4d1a03daf51ef875b
https://pubmed.ncbi.nlm.nih.gov/7751412

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání